Screener
Neurocrine Biosciences NBIX Other Non-Current Liabilities
Other Non-Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Neurocrine Biosciences in its filing.
Tagged under the XBRL concept us-gaap:OtherLiabilitiesNoncurrent.
The source filing: Neurocrine Biosciences’s 10-Q, filed May 5, 2026. Open the filing →
- Filed
- May 5, 2026, 4:02 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000914475-26-000026
FAQ
- What is Neurocrine Biosciences's other non-current liabilities?
- Neurocrine Biosciences (NBIX) reported other non-current liabilities of $260.9M in Q1 2026.
- How has Neurocrine Biosciences's other non-current liabilities changed year-over-year?
- Neurocrine Biosciences's other non-current liabilities increased by 43.7% year-over-year, from $181.6M to $260.9M.
- What is the long-term trend for Neurocrine Biosciences's other non-current liabilities?
- Over 5 years (2020 to 2025), Neurocrine Biosciences's other non-current liabilities has grown at a 86.6% compound annual growth rate (CAGR), from $9.7M to $219.7M.
- What does other non-current liabilities mean?
- Miscellaneous long-term obligations not classified in specific categories — pension liabilities, environmental remediation, and other long-term accruals.
Ask your AI about Neurocrine Biosciences's other non-current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude